LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about IRLAB Therapeutics AB…

Similar companies to IRLAB Therapeutics AB

IRLAB Therapeutics AB Tech Stack

IRLAB Therapeutics AB uses 8 technology products and services including LinkedIn Ads, RSS, Microsoft 365, and more. Explore IRLAB Therapeutics AB's tech stack below.

  • LinkedIn Ads
    Advertising
  • RSS
    Content Management System
  • Microsoft 365
    Email
  • PHP
    Programming Languages
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics
  • WPML
    Web Platform Extensions

Media & News

IRLAB Therapeutics AB's Email Address Formats

IRLAB Therapeutics AB uses at least 1 format(s):
IRLAB Therapeutics AB Email FormatsExamplePercentage
First.Last@irlab.seJohn.Doe@irlab.se
50%
First.Last@irlab.seJohn.Doe@irlab.se
50%

Frequently Asked Questions

What is IRLAB Therapeutics AB's official website and social media links?

Minus sign iconPlus sign iconIRLAB Therapeutics AB's official website is irlab.se and has social profiles on LinkedInCrunchbase.

What is IRLAB Therapeutics AB's SIC code NAICS code?

Minus sign iconPlus sign iconIRLAB Therapeutics AB's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does IRLAB Therapeutics AB have currently?

Minus sign iconPlus sign iconAs of December 2025, IRLAB Therapeutics AB has approximately 36 employees across 2 continents, including EuropeAsia. Key team members include Chief Executive Officer: K. T.Head Of Chemistry, Manufacturing And Controls: L. N.Director Clinical Science & Biometrics: F. H.. Explore IRLAB Therapeutics AB's employee directory with LeadIQ.

What industry does IRLAB Therapeutics AB belong to?

Minus sign iconPlus sign iconIRLAB Therapeutics AB operates in the Biotechnology Research industry.

What technology does IRLAB Therapeutics AB use?

Minus sign iconPlus sign iconIRLAB Therapeutics AB's tech stack includes LinkedIn AdsRSSMicrosoft 365PHPCloudflare Bot ManagementGoogle Tag ManagerGoogle AnalyticsWPML.

What is IRLAB Therapeutics AB's email format?

Minus sign iconPlus sign iconIRLAB Therapeutics AB's email format typically follows the pattern of First.Last@irlab.se. Find more IRLAB Therapeutics AB email formats with LeadIQ.

How much funding has IRLAB Therapeutics AB raised to date?

Minus sign iconPlus sign icon As of December 2025, IRLAB Therapeutics AB has raised $12M in funding. The last funding round occurred on Jul 18, 2025 for $12M.

When was IRLAB Therapeutics AB founded?

Minus sign iconPlus sign iconIRLAB Therapeutics AB was founded in 2013.

IRLAB Therapeutics AB

Biotechnology ResearchVästra Götaland, Sweden11-50 Employees

IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam.
 
IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its proprietary systems biology-based Integrative Screening Process (ISP) research platform. In addition to IRLAB’s strong clinical pipeline, the company is also progressing two preclinical programs, IRL942 and IRL757, towards Phase I studies. IRLAB is listed on Nasdaq Stockholm. More information on www.irlab.se.

Section iconCompany Overview

Website
irlab.se
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $12M

    IRLAB Therapeutics AB has raised a total of $12M of funding over 6 rounds. Their latest funding round was raised on Jul 18, 2025 in the amount of $12M.

  • $1M

    IRLAB Therapeutics AB's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $12M

    IRLAB Therapeutics AB has raised a total of $12M of funding over 6 rounds. Their latest funding round was raised on Jul 18, 2025 in the amount of $12M.

  • $1M

    IRLAB Therapeutics AB's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    K. T.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. N.
    Head Of Chemistry, Manufacturing And Controls
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. H.
    Director Clinical Science & Biometrics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. A.
    Director Of Biology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Director Clinical Operations & Quality
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    O. V. V.
    Clinical Project Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. E.
    Senior Research Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. B.
    Senior Researcher, Chemistry
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. K.
    Senior Research Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. W.
    Senior Scientist And Ai Expert
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.